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LETTERS
Hand, Foot, and 
Mouth Disease  




To the Editor: Hand, foot, and 
mouth disease (HFMD) is an acute, 
febrile viral infection characterized 
by vesicular exanthema on the 
palms of the hands, soles of the 
feet, and oral mucosa. The infection 
is transmitted through oral and 
respiratory secretions, vesicular fluid, 
and/or feces of affected persons. The 
most common etiologic agents are 
coxsackievirus (CV) A16 and human 
enterovirus (HEV) 71, but other 
HEVs, mainly belonging to species 
A, have also been associated with 
illness (1). HFMD mainly affects 
infants and children <5 years of age.
On May 10, 2011, an outbreak 
of HFMD was reported in a daycare 
center in the city of Irun in Basque 
Country, Spain. Monitoring 
subsequently was conducted for 
HFMD cases  among children in 
the health district that contained 
the daycare center (a total of 4,540 
children <14 years of age). Children 
with fever and vesicular rash on 
the palms and/or soles and in the 
mouth were considered HFMD 
patients. Pharyngeal and/or dermal 
exudate and/or feces were collected 
for virologic confirmation from 37 
representative HFMD patients (17 
with multiple specimens) selected by 
sentinel pediatricians in outpatient 
clinics. Viral RNA was extracted 
directly from specimens (NucliSENS 
Easy-Mag, Bio-Mèrieux, Marcy-
l’Étoile, France) and was used in the 
amplification methods. Enterovirus 
RNA was detected by an in-house 
real-time PCR that amplified a 
fragment within the 5′  untranslated 
region by using described primers 
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protein 1 gene was amplified by 
using described methods (3), 
followed by partial sequencing of 
the obtained amplicons by using the 
3130XL Genetic Analyzer (Applied 
Biosystems, Foster City, CA, USA). 
Control measures recommended were 
frequent and careful handwashing 
with soap and running water by 
children and staff and increasing the 
cleaning of surfaces and objects in 
daycare centers and nursery schools.
During April–September 2011, 
a total of 99 cases of HFMD were 
notified; 53 patients were boys. 
Twenty-five cases occurred in the 
daycare center, all before May 13 
(attack rate 55.6%), and 74 were 
community acquired, occurring mainly 
after that date. All cases occurred in 
children <4 years of age (median age 
1.8 years; incidence 77 cases/1,000 
inhabitants). The highest incidence 
occurred in children 12–36 months of 
age (122.4 cases/1,000 inhabitants). 
In addition to a papulovesicular rash 
on the palms, soles, and/or buttocks, 
89 (90%) HFMD patients showed a 
perioral papulovesicular rash that did 
not extend to the rest of the face. None 
of the children were hospitalized. 
Enterovirus was detected in 49 
samples (28 pharyngeal, 2 dermal, 
19 fecal) from 33 HFMD patients. 
For 30 of these patients, the samples 
were sufficient for genotyping. CVA6 
was detected in 27 (90%) patients and 
CVA10 in 2 (7%) patients; for 1 patient, 
no genotype was obtained. Seven 
(7%) of the 99 children with HFMD 
were brought for medical assistance 
for onychomadesis during the 9–67 
days after the HFMD episode. In 2 of 
them, HFMD had been virologically 
confirmed as being caused by CVA6.
Our results suggest that CVA6 can 
cause HFMD outbreaks that develop 
rapidly and reach a high incidence 
in children. Despite the mildness of 
the disease, the high attack rate in 
the daycare center alarmed families 
and staff. HFMD is not subject to 
epidemiologic surveillance in Spain, 
and thus its real incidence cannot be 
identified.
Although CVA6 has long been 
known to cause HFMD (1), it has 
not usually been considered to play 
a major role in this disease. Except 
in a few countries, CVA6 has been 
infrequently detected until recent 
years. However, since 2008, this 
virus has caused major outbreaks of 
HFMD in some countries of eastern 
Asia and Europe and, more recently, 
in the United States (4–9); the CVA6 
strains in this outbreak shared >97% 
of nucleotide identities in the viral 
protein 1 gene and showed sequence 
similarity >94% with the strains 
that caused these outbreaks. These 
strains segregated in a phylogenetic 
tree (Figure), supporting the recent 
international spread of emerging 
CVA6 genetic variants (4). In Taiwan 
and Japan, the emergence of these 
strains has been associated with a 
change in the predominant clinical 
expression of the infections produced 
by CVA6, from herpangina before 
2009 to HFMD in 2010–2011 (7,8). 
The development of a perioral rash 
has also been associated to HFMD 
caused by CVA6 (10). 
Although the course of HFMD is 
usually self-limiting, illness and death 
rates vary among outbreaks. Severe 
illness is more frequent in outbreaks 
caused by HEV71 (1); in outbreaks 
caused by CVA6 in Taiwan and the 
United States, the illness affected a 
broader spectrum of skin sites and 
was associated with more severe and 
extensive rash than was HFMD caused 
by other coxsackieviruses (7,9).
In conclusion, reports of HFMD 
outbreaks associated with CVA6 
are increasing. Improved HFMD 
surveillance is required, with virus 
genotyping as a key element.
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Rabies Update  
for Latin America 
and the Caribbean
To the Editor: Rabies incidence 
in Latin America and the Caribbean 
has decreased and several countries 
(Uruguay, Chile, Costa Rica, Mexico, 
and Panama) and areas of Peru, Brazil, 
and Argentina are free of human rabies 
transmitted by dogs, although there are 
certain areas to which this disease is still 
endemic (1). Coordinated actions for 
regional elimination of human rabies 
transmitted by dogs began in 1983 in 
Latin America and the Caribbean with 
the assistance of the Pan American 
Health Organization (PAHO). This 
effort has led to an ≈90% reduction 
of human and canine rabies (2). In 
this region, rabies is associated with 
poverty and considered a neglected 
disease (3). Resolution 19 of the 49th 
Directing Council of PAHO in 2009 
regarding neglected diseases and 
other infections related to poverty set 
a target for eliminating human rabies 
transmitted by dogs by 2015. PAHO 
is currently developing strategies to 
assist countries during this period (4).
Since 2010, a total of 111 human 
rabies cases transmitted by bats, 
dogs, and other animal species were 
reported from Latin America and the 
Caribbean: 40 transmitted by dogs and 
63 by bats (Table). Although a major 
reduction in human rabies transmitted 
by dogs was observed in 2010 (only 
6 cases), the total number of cases 
increased to 24 in 2011; most were 
confirmed by laboratory testing.
The higher risk areas for human 
rabies transmitted by dogs, for which 
more collaboration and financial 
support are urgently needed, are 
Haiti, Bolivia, Guatemala, Dominican 
Republic, and parts of Brazil 
(Maranhão State) and Peru (Puno 
Region). Unfavorable conditions in 
which persons in these areas are living 
limit control strategies and maintain 
rabies transmission (3).
According to the PAHO 
Epidemiologic Surveillance System 
for Rabies, during 2010–2012, 
Bolivia and Haiti had the highest 
incidence of human rabies transmitted 
by dogs in the Western Hemisphere: 
15% (6/40) and 40% (16/40) of all 
cases, respectively (5). Many factors, 
including national disasters and social, 
cultural, and economic factors, have 
interfered with canine rabies control 
programs in these countries.
Bolivia has a population of 10 
million, and 60.0% of the population is 
considered below the national poverty 
line. This country has poor suburbs 
on the outskirts of large cities, with 
large populations of unowned dogs 
and limited resources to implement 
dog mass vaccination campaigns and 
animal birth control programs. Haiti 
has a population of >10 million, and 
77% of the population is considered 
below the national poverty line. In 
2010, Haiti was devastated by a major 
earthquake that affected all sectors, 
including laboratory diagnosis for 
rabies (6). After the earthquake, 
the country was struck by a cholera 
epidemic. Financial resources have 
been diverted to control such priorities 
and to provide humanitarian aid. Haiti 
and Bolivia heavily depend on technical 
cooperation and donations from other 
governments or institutions, and are a 
high priority for elimination of human 
rabies transmitted by dogs (7).
Another challenge for Latin 
America and the Caribbean is 
development of a common strategy for 
preventing human rabies transmitted 
by bats, especially in remote areas in 
the Amazon region (Peru, Ecuador, 
and Brazil) and Mexico (7), from 
which 97% of human rabies cases 
were reported during this period. 
Since 2000, vampire bats have been 
the leading cause of human rabies 
in Latin America and the Caribbean 
(8). Comparison of data for 2010–
2012 with data for the previous 3 
years shows a 5.2% increase in bat-
transmitted human rabies, especially 
during 2011, which accounted for 
≈53% of reports during the past 3 
years (5).
Bats have been identified as 
a reservoir for many Lyssavirus 
spp. genotypes, and the geographic 
distribution of variants has been 
associated with climate changes and 
ecologic imbalances. Spread of bats 
has been facilitated by human-made 
shelters near human dwellings (9).
Although rabies control in Latin 
America and the Caribbean has 
been successful, certain approaches 
currently used, such as mass 
vaccination campaigns for dogs, 
postexposure prophylaxis, and 
epidemiologic surveillance, require 
improvement in some countries. In 
addition, allocation of resources is 
needed to enhance national programs 
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